Impact of Bread Diet on Intestinal Dysbiosis and Irritable B... | Clinical Trial | StuddyBuddy@endsection Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05656391

Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis

Conditions: Ulcerative Colitis in Remission

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 31
Sponsor: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Location: Spain

Summary

The present study aimed to compare the in vivo prebiotic properties of bread produced by traditional breadmaking techniques with that made using a modern breadmaking method on Irritable Bowel Syndrome-like symptoms in patients with quiescent Ulcerative Colitis. The expected outcome of the differential effects was a change in the faecal microbiome composition, which may indicate changes in the mucosa-associated microbiota.

Eligibility Criteria

Inclusion Criteria:Patients diagnosed with ulcerative colitis according to established clinical and histological criteria as common clinical practiceRemission of ulcerative colitis defined as a total Mayo score ≤2 and faecal calprotectin values under 250 ng/gSubjects aged over 18 yearsModerate-to-severe IBS-like symptomatology defined by Rome IV criteria and IBS Symptom Severity Score (IBS-SSS) > 175.Exclusion Criteria:Presence of flare-up of UCCoeliac disease, colectomy, or intestinal resectionAntibiotic intake, prebiotic or probiotic treatment within 3 months before the studyAny malignancy, pregnancy, or breastfeedingIntake of medication potentially influencing gastrointestinal functionDisability to give informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05656391). StuddyBuddy aggregates publicly available trial information.